PH16454A - 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid - Google Patents

3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid

Info

Publication number
PH16454A
PH16454A PH25462A PH25462A PH16454A PH 16454 A PH16454 A PH 16454A PH 25462 A PH25462 A PH 25462A PH 25462 A PH25462 A PH 25462A PH 16454 A PH16454 A PH 16454A
Authority
PH
Philippines
Prior art keywords
tetramethyl
hexadecapentaenoic acid
hexadecapentaenoic
acid
Prior art date
Application number
PH25462A
Other languages
English (en)
Inventor
Yamatsu Isao
Tagaya Osamu
Inai Yuichi
Suzuki Kouichi
Abe Shinya
Abe Kouichi
Suzuki Takeshi
Yamada Kouji
Suzuki Yoshikazu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH16454A publication Critical patent/PH16454A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH25462A 1980-04-07 1981-04-02 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid PH16454A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4455880A JPS56140949A (en) 1980-04-07 1980-04-07 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenic acid

Publications (1)

Publication Number Publication Date
PH16454A true PH16454A (en) 1983-10-13

Family

ID=12694821

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25462A PH16454A (en) 1980-04-07 1981-04-02 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid

Country Status (5)

Country Link
US (2) US4988732A (cg-RX-API-DMAC10.html)
JP (1) JPS56140949A (cg-RX-API-DMAC10.html)
AT (1) AT374781B (cg-RX-API-DMAC10.html)
BE (1) BE888290A (cg-RX-API-DMAC10.html)
PH (1) PH16454A (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6160612A (ja) * 1984-08-31 1986-03-28 Eisai Co Ltd 制癌効果増強剤
JPH075460B2 (ja) * 1985-02-22 1995-01-25 エーザイ株式会社 制癌剤
JPH10167960A (ja) * 1996-12-12 1998-06-23 Les-Bell:Kk 肝細胞ガン再発抑制剤
DE60001683T2 (de) 1999-04-23 2003-12-18 Nikken Chemicals Co., Ltd. Verfahren zur Reinigung von 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenonsäure
WO2001080854A1 (en) * 2000-04-24 2001-11-01 Nikken Chemicals Co., Ltd. Activators for peroxisome proliferator-activated receptor
JPWO2003097034A1 (ja) * 2002-05-17 2005-09-15 日研化学株式会社 ＴＧＦ−α発現抑制剤
CN1303993C (zh) 2002-08-20 2007-03-14 日研化学株式会社 软胶囊制剂
JP4520203B2 (ja) * 2003-04-18 2010-08-04 興和株式会社 ポリプレニル系化合物の製造方法
EP1733723B1 (en) * 2004-02-25 2011-07-13 The University of Tokyo Medicine capable of inhibiting activation of transcription factor klf5
CA2613574A1 (en) * 2005-07-06 2007-01-11 Nicholas Piramal India Limited Improved processes for the preparation of purified solanesol, solanesyl bromide and solanesyl acetone
ES2555782T3 (es) 2007-03-30 2016-01-08 Kowa Company, Ltd. Fármaco para prevenir y/o tratar hígado graso o esteatosis hepática no alcohólica
CN101720222B (zh) 2007-06-21 2016-09-07 学校法人城西大学 具有促进肝细胞增殖作用的药物
WO2012041949A1 (en) * 2010-10-01 2012-04-05 Dsm Ip Assets B.V. Improved synthesis of peretinoin
EP2621879B1 (en) * 2010-10-01 2020-06-17 DSM IP Assets B.V. Synthesis of peretinoin
JP7655479B2 (ja) 2020-11-20 2025-04-02 国立研究開発法人国立長寿医療研究センター ［１１ｃ］標識非環式レチノイド、中枢神経系活性化剤及びそれらの製造方法。

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2649138A1 (de) * 1975-10-30 1977-05-12 Hoffmann La Roche Verfahren zur herstellung von polyenverbindungen
JPS52144614A (en) * 1976-05-27 1977-12-02 Eisai Co Ltd Polyprenyl carboxylic acid compounds and hypo-tensor containing same
JPS601283B2 (ja) * 1976-06-08 1985-01-14 帝人株式会社 包接化合物並びにその製造法
JPS5731615A (en) * 1980-07-31 1982-02-20 Eisai Co Ltd Remedy for skin disease with keratinization
NL191744C (nl) * 1980-04-07 1996-06-04 Eisai Co Ltd Farmaceutisch preparaat met werking tegen epitheelletsels.

Also Published As

Publication number Publication date
US4988732A (en) 1991-01-29
AT374781B (de) 1984-05-25
ATA161381A (de) 1983-10-15
JPS6332058B2 (cg-RX-API-DMAC10.html) 1988-06-28
JPS56140949A (en) 1981-11-04
US4917829A (en) 1990-04-17
BE888290A (fr) 1981-07-31

Similar Documents

Publication Publication Date Title
CY1453A (en) 1,3-dioxan-5-ylalkenoic acids
JPS5753490A (en) 5'-aminoalkyl-4',4,8-trialkylpsoralens
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
GB2140016B (en) 1,2-epoxy-3-oxo-chola-4,6-dien-24-oic acid derivatives
PH16454A (en) 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
CS997683A2 (en) Zpusob vyroby derivatu 1,4:3,6-dianhydrohexitolu
GB2071665B (en) 18-glycyrrhizinic acid
GB2073752B (en) 2,6-diaminobularines
GB2075012B (en) 4,1-benzoxazepines
GB2073750B (en) 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
GB2135303B (en) 3,5-dinitrophthalimides
AU1802983A (en) 2,2-dimethyl-5-phenoxypentanoic acid benzamides
IL68879A0 (en) N-substituted-3,4,5,6-tetrahydrophthalamic acid derivatives
ZA813951B (en) 2,3-bis-hydroxybenzyl-derivatives
ZW6581A1 (en) 2,5-disubstituted-4-pirimidones
NZ197556A (en) 1,1 -alkylenediiminobis(4-( -aminoalkylamino)-anthraquinones
JPS57116050A (en) 2,4-diamino-5-benzylpyrimidine
JPS57108059A (en) Manufacture of 1,4-diamino-anthraquinone-2- sulfonic acid
GB2086387B (en) 1,8-dihydroxy-9-anthrones
GB2080791B (en) 1,4-benzoxazines
JPS57185263A (en) 2,6-diaryl-pyridinecarboxylic acids
GB2089811B (en) 23,25-dihydroxyvitamin d3
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
AU533721B2 (en) 6,6-diiodopenicillanic acid
ZA81222B (en) 1,3-diformyloxy -2-bromo-2-nitropropane

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 13